期刊文献+

人白血病细胞株对L-门冬酰胺酶敏感性与门冬酰胺合成酶表达水平的相关性 被引量:2

Relationship between Asparagine Synthetase Expression Level and Cell Sensitivity to L-asparaginase in Human Leukemic Cell Lines
下载PDF
导出
摘要 本研究探讨人白血病细胞株门冬酰胺合成酶(asparagine synthetase,AsnS)的表达水平及与白血病细胞株对L-Asparaginase(L-Asp)敏感性的关系。用实时定量PCR技术(real-time quantitative PCR,RQ-PCR)检测Jurkat,HL-60,U937,NB4,THP-1,Namalwa,Karpas299和K562等8种细胞株基础的和经L-Asp处理后的AsnS表达水平,用CCK-8实验检测细胞对L-Asp处理的敏感性。结果表明,8种细胞株之间AsnS的基础表达水平存在很大程度的变异,经L-Asp处理后细胞株的AsnS表达显著上调(p<0.05),AsnS低水平表达细胞对L-Asp相对敏感,而AsnS高表达细胞对L-Asp相对耐药。在8种细胞株中,U937对L-Asp高度敏感,其AsnS表达水平最低,而K562细胞株对L-Asp天然耐药,AsnS表达水平最高。结论:AsnS在天门冬氨酸耗竭后的细胞生物学行为中起着重要的作用,AsnS的表达水平反映了细胞对L-Asp的敏感性,L-Asp在AsnS低表达白血病的治疗中有潜在的应用价值。 This study was purposed to explore the relationship between asparagine synthetase (AsnS) mRNA expression level and the sensitivity of leukemic cell lines to L-asparaginase. The AsnS mRNA expression level in 8 cell lines (Jurkat, HL-60, U937, NB4, THP-1, Namalwa, Karpas299 and K562) was determined by real-time quantitative PCR (RQ-PCR) based on fluorescence dye Eva Green before and after treatment with L-Asp, and the cell proliferation rates were analyzed by CCK-8 assay. The results showed that there was a significant disparity of AsnS expression level in 8 cell lines, and there were significant increases of AsnS expression level in cells co-cultured with L-Asp (p 〈 0.05). Of all these eight cell lines, cells sensitive to L-asparaginase had lower AsnS expression level and cells resistant to L-asparaginase had higher AsnS expression. U937 which was the most sensitive to L-asparaginase had the lowest AsnS expression level, while K562 was natural resistant to L-asparaginase and possessed of the highest AsnS level. It is concluded that the AsnS plays a critical role in regulating cellular biological behavior after depletion of asparagine, the AsnS mRNA expression level in cells reflects the sensitivity of cells to L-Asp. The results may imply the possibility for the use of L-asparaginase in leukemia with lower AsnS expression level.
出处 《中国实验血液学杂志》 CAS CSCD 2010年第3期559-563,共5页 Journal of Experimental Hematology
基金 国家自然科学基金项目资助 编号30672271
关键词 白血病 门冬酰胺合成酶 左旋门冬酰胺酶 白血病细胞株 leukemia asparagine synthetase L-Asparaginase leukemia cell line
  • 相关文献

参考文献14

  • 1Jousse C, Averous J, Bruhat A, et al. Amino acids as regulators of gene expression : molecular mechanisms. Biochem Biophys Res Commun, 2004; 313(2) :447 -452.
  • 2Irino T, Kitoh T, Koami K, et al. Establishment of real-time polymerase chain reaction method for quantitative analysis of asparagine synthetase expression. J Mol Diagn, 2004 ; 6 ( 3 ) :217 - 224.
  • 3Pui CH, Campana D, Pei D, et al. Treating childhood acute lymphoblastic leukemia without cranial irradiation. N Engl J Med, 2009 ; 360(26) :2730 -2741.
  • 4Dabbers A, Wurthwein G, Muller HJ, et al. Asparagine synthetase activity in paediatric acute leukaemias: AML-M5 subtype shows lowest activity. Br J Haematol, 2000;109(2) :427 -429.
  • 5Aslanian AM. , Fletcher BS and Kilberg MS. Asparagine synthetase expression alone is sufficient to induce 1-asparaginase resistance in MOLT-4 human leukaemia cells. Biochem J, 2001 ; 357 ( Pt 1 ) : 321 - 328.
  • 6Ando M, Sugimoto K, Kitoh T, et al. Selective apoptosis of natural killer-cell tumours by 1-asparaginase. Br J Haematol, 2005; 130 (6) :860 -868.
  • 7Peng H, Shen N, Qian L, et al. Hypermethylation of CpG islands in the mouse asparagine synthetase gene: relationship to asparaginase sensitivity in lymphoma cells. Partial methylation in normal cells. Br J Cancer, 2001 ;85(6) :930 -935.
  • 8Krejci O, Starkova J, Otova B, et al. Upregulation of asparagine synthetase fails to avert cell cycle arrest induced by L-asparaginase in TEL/AML1-positive leukaemic cells. Leukemia, 2004 ; 18 ( 3 ) : 434 -441.
  • 9Medina MA. Glutamine and cancer. J Nutr, 2001 ;131 (9 Suppl) : 2539S - 2542S.
  • 10Rotoli BM, Uggeri J, Dall'Asta V, et al. Inhibition of glutamine synthetase triggers apoptosis in asparaginase-resistant cells. Cell Physiol Biochem, 2005 ;15(6) :281 -292.

同被引文献41

  • 1陈福雄,崔彦芹,吴梓梁,叶铁真,赖永洪,邹亚伟,卢成瑜,关镜明,卫凤桂,张辉.左旋门冬酰胺酶治疗儿童急性淋巴细胞白血病的药代和药效动力学研究[J].中华血液学杂志,2005,26(2):100-102. 被引量:2
  • 2Tucci F, Arico M. Treatment of pediatric acute lymphoblastic leukemia. Haematologica, 2008 ;93 ( 8 ) : 1124 - 1128.
  • 3Hijiya N, Stewart CF, Zhou Y, et al. Phase II study of topotecan in combination with dexamethasone, asparaginase, and vincristine in pediatric patients with acute lymphoblastic leukemia in first relapse. Cancer,2008 ; 112 (9) : 1983 - 1991.
  • 4Merryman R, Stevenson KE, Gostic WN, et al. Asparaginase- associated myelosuppression and effects on dosing of other chemotherapeutic agents in childhood acute lymphoblastic leukemia. Pediatr Blood Cancer, 2012 ; 59 ( 5 ) :925 - 927.
  • 5Avramis VI. Asparaginases: a successful class of drugs against leukemias and lymphomas. J Pediatr Hematol Oncol,2011 ;33 (8) : 573 - 579.
  • 6Appel I M, van Kessel-Bakvis C, Stigter R, et al. Influence of two different regimens of concomitant treatment with asparaginase and dexamethasone on hemostasis in childhood acute lymphoblastic leukemia. Leukemia,2007 ;21 ( 11 ) :2377 - 2380.
  • 7Dinndorf PA, Gootenberg J, Cohen MH, et al. FDA drug approval summary, pegaspargase ( oncaspar ) for the f'u'st-line treatment of children with acute lymphoblastic leukemia (ALL). Oncologist,2007 ; 12 ( 8 ) :991 - 998.
  • 8Pieters R, Hunger SP, Boos J, et al. L-asparaginase treatment in acute lymphoblastic leukemia: a focus on Erwinia asparaginase. Cancer,2011 ;117(2) :238 -249.
  • 9Papageorgiou AC, Posypanova GA, Andersson CS, et al. Structural and functional insights into Erwinia carotovora L- asparaginase. FEBS J,2008 ;275 ( 17 ) :4306 - 4316.
  • 10Pieters R, Appel I, Kuehnel HJ, et al. Pharmacokinetics, pharmacodynamics, efficacy, and safety of a new recombinant asparaginase preparation in children with previously untreated acute lymphoblastic leukemia: a randomized phase 2 clinical trial. Blood,2008 ;112(13) :4832 -4838.

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部